Literature DB >> 13115369

The mechanism of inhibition of cholinesterases by organophosphorus compounds.

W N ALDRIDGE, A N DAVISON.   

Abstract

Entities:  

Keywords:  CHOLINESTERASE/antagonists; PHOSPHATES/effects

Mesh：

Substances：

Year:  1953        PMID： 13115369      PMCID： PMC1269530          DOI： 10.1042/bj0550763

Source DB:  PubMed          Journal:  Biochem J        ISSN： 0264-6021            Impact factor:   3.857


× No keyword cloud information.
  6 in total

1.  Acetylcholinesterase. XIII. Reactivation of alkyl phosphate-inhibited enzyme.

Authors:  I B WILSON
Journal:  J Biol Chem       Date:  1952-11       Impact factor: 5.157

2.  [The inhibition of erythrocyte cholinesterase by tri-esters of phosphoric acid. III. The nature of the inhibitory process].

Authors:  W N ALDRIDGE
Journal:  Biochem J       Date:  1953-06       Impact factor: 3.857

3.  The inhibition of erythrocyte cholinesterase by tri-esters of phosphoric acid. I. Diethyl p nitrophenyl phosphate (E600) and analogues.

Authors:  W N ALDRIDGE; A N DAVISON
Journal:  Biochem J       Date:  1952-04       Impact factor: 3.857

4.  The inhibition of erythrocyte cholinesterase by tri-esters of phosphoric acid. II. Diethyl p-nitrophenyl thionphosphate (E605) and analogues.

Authors:  W N ALDRIDGE; A N DAVISON
Journal:  Biochem J       Date:  1952-12       Impact factor: 3.857

5.  Return of cholinesterase activity in the rat after inhibition by organophosphorus compounds. I. Diethyl p-nitro-phenyl phosphate (E 600, paraoxon).

Authors:  A N DAVISON
Journal:  Biochem J       Date:  1953-07       Impact factor: 3.857

6.  Serum esterases. II. An enzyme hydrolysing diethyl p-nitrophenyl phosphate (E600) and its identity with the A-esterase of mammalian sera.

Authors:  W N ALDRIDGE
Journal:  Biochem J       Date:  1953-01       Impact factor: 3.857
  6 in total
  20 in total

1.  The esteratic and chylolytic properties of post-heparin plasma and their role in lipaemia clearing.

Authors:  S W LEVY; R L SWANK
Journal:  J Physiol       Date:  1955-02-28       Impact factor: 5.182

2.  Return of cholinesterase activity in the rat after inhibition by organophosphorus compounds. 2. A comparative study of true and pseudo cholinesterase.

Authors:  A N DAVISON
Journal:  Biochem J       Date:  1955-06       Impact factor: 3.857

3.  SELECT bibliography on the toxicity of pesticides to man and animals; 1953-1955.

Authors: 
Journal:  Bull World Health Organ       Date:  1957       Impact factor: 9.408

4.  The reactivation by oximes and hydroxamic acids of cholinesterase inhibited by organo-phosphorus compounds.

Authors:  A F CHILDS; D R DAVIES; A L GREEN; J P RUTLAND
Journal:  Br J Pharmacol Chemother       Date:  1955-12

5.  Studies on cholinesterase. 10. Return of cholinesterase activity in the rat after inhibition by carbamoyl fluorides.

Authors:  D K MYERS
Journal:  Biochem J       Date:  1956-04       Impact factor: 3.857

6.  Effect of nicotinhydroxamic acid methiodide on human plasma cholinesterase inhibited by organophosphates containing a dialkylphosphato group.

Authors:  F HOBBIGER
Journal:  Br J Pharmacol Chemother       Date:  1955-09

7.  The kinetics of reactivation, by oximes, of cholinesterase inhibited by organophosphorus compounds.

Authors:  D R DAVIES; A L GREEN
Journal:  Biochem J       Date:  1956-08       Impact factor: 3.857

8.  The spontaneous and induced recovery of fly-brain cholinesterase after inhibition by organophosphates.

Authors:  D C Mengle; R D O'brien
Journal:  Biochem J       Date:  1960-04       Impact factor: 3.857

9.  The mode of recovery of cholinesterase activity in vivo after organophosphorus poisoning. 1. Erythrocyte cholinesterase.

Authors:  L C Blaber; N H Creasey
Journal:  Biochem J       Date:  1960-12       Impact factor: 3.857

10.  Human paraoxonase 1 hydrolysis of nanomolar chlorpyrifos-oxon concentrations is unaffected by phenotype or Q192R genotype.

Authors:  R Hunter Coombes; Edward C Meek; Mary Beth Dail; Howard W Chambers; Janice E Chambers
Journal:  Toxicol Lett       Date:  2014-08-02       Impact factor: 4.372
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.